Abstract:Numerous studies have proved that cell-nonautonomous regulation of neoplastic cells is a distinctive and essential characteristic of tumorigenesis. Two way communications between the tumor and the stroma, or within the tumor significantly influence disease progression and modify treatment responses. In the tumor microenvironment (TME), malignant cells utilize paracrine signaling initiated by adjacent stromal cells to acquire resistance against multiple types of anticancer therapies, wherein extracellular vesicles (EVs) substantially promote such events. EVs are nanoscaled particles enclosed by phospholipid bilayers, and can mediate intercellular communications between cancerous cells and the adjacent microenvironment to accelerate pathological proceeding. Here we review the most recent studies of EV biology and focus on key cell lineages of the TME and their EV cargoes that are biologically active and responsible for cancer resistance, including proteins, RNAs, and other potentially essential components. Since EVs are emerging as novel but critical elements in establishing and maintaining hallmarks of human cancer, timely and insightful understanding of their molecular properties and functional mechanisms would pave the road for clinical diagnosis, prognosis, and effective targeting in the global landscape of precision medicine. Further, we address the potential of EVs as promising biomarkers in cancer clinics and summarize the technical improvements in EV preparation, analysis, and imaging. We highlight the practical issues that should be exercised with caution to guide the development of targeting agents and therapeutic methodologies to minimize cancer resistance driven by EVs, thereby allowing to effectively control the early steps of disease exacerbation.

Small Extracellular Vesicles-Mediated Cellular Interactions Between Tumor Cells and Tumor-Associated Macrophages: Implication for Immunotherapy.

Tumor Cell-derived Extracellular Vesicles in Modulating Phenotypes and Immune Functions of Macrophages: Mechanisms and Therapeutic Applications.

Roles of M1 Macrophages and Their Extracellular Vesicles in Cancer Therapy

Extracellular Vesicles Derived from Macrophages: Current Applications and Prospects in Tumors

Exosomes: A Potential Therapeutic Tool Targeting Communications Between Tumor Cells and Macrophages.

Crosstalk between extracellular vesicles and tumor-associated macrophage in the tumor microenvironment

Crosstalk among long non-coding RNA, tumor-associated macrophages and small extracellular vesicles in tumorigenesis and dissemination

Exosomal Micrornas Shuttling Between Tumor Cells and Macrophages: Cellular Interactions and Novel Therapeutic Strategies

Extracellular vesicles remodel tumor environment for cancer immunotherapy

Modulatory effects of cancer stem cell-derived extracellular vesicles on the tumor immune microenvironment

The interplay between the tumor microenvironment and tumor-derived small extracellular vesicles in cancer development and therapeutic response

Tumor-derived extracellular vesicles in melanoma immune response and immunotherapy

Tumor-derived extracellular vesicles regulate macrophage polarization: role and therapeutic perspectives

Engineering extracellular vesicles derived from macrophages for tumor therapy: a review

The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapy

Extracellular vesicles in the tumor microenvironment: old stories, but new tales

Tumor-Derived Extracellular Vesicles Regulate Cancer Progression in the Tumor Microenvironment

Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages

Extracellular vesicles derived from immune cells: Role in tumor therapy

Extracellular vesicles in the tumor immune microenvironment

Extracellular vesicles in the tumor microenvironment: Therapeutic resistance, clinical biomarkers, and targeting strategies